Using chemical biology, animal behavioral analysis, and AD-correlated proteomics, we discovered a noncanonical, translation-regulatory function of aberrantly activated G9a that defines the proteopathologic nature of AD. This evidence concerns the gene EHMT2 and Alzheimer disease.